Drug Development Services
-
mAb And r-Proteins Contract Testing, Development, And Manufacturing Services
10/16/2023
Accelerate The Biologic Drug Development Journey
With Millipore® CTDMO Services we provide deep expertise and flexible solutions across all stages of development and manufacturing for monoclonal antibodies, bi-specific antibodies, fusion proteins, or antibody fragments. We work with our clients to balance risk, optimize speed, and support all aspects of regulatory compliance on the journey to market.
-
SUREmAb™ - Monoclonal Antibody Development, The Way It's Meant To Be
8/4/2023
Leverage robust development strategies and enable an optimized process for mAb development and manufacturing, efficiency and speed with exceptional quality, and high titers with lower-cost workflows for maximum ROI.
-
Controlled Expansion Of Supercritical Solutions (CESS®) Technology
4/24/2023
Nanoform’s award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology is a bottom-up nanoparticle engineering approach that enables the creation of API nanoparticles and can unlock the full therapeutic potential of small molecule drugs.
-
Viral Vector Contract Testing, Development, & Manufacturing Services (CTDMO)
9/7/2023
ADVANCING CELL AND GENE THERAPIES FOR PATIENTS
Millipore® CTDMO Services delivers expertise and flexible solutions for viral vector development and manufacturing to advance cell and gene therapies from preclinical through commercial production.
-
Protein L Resin For Affinity Capture
5/3/2023
MabSelect™ VL resin — protein L resin for affinity capture of antibody Fabs, bispecifics, and other variants containing a kappa light chain.
-
End-To-End Ophthalmic Drug Development Solutions
4/9/2024
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions support programs from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
SUREtechnology Platform™
8/4/2023
Explore how an advanced Cell Line Development (CLD) platform for new biologics can enable CHO-based cell line development; ensure premium, stable, and high-yield results; overcome common expression bottlenecks; and provide robust verification, genomic characterization, and monoclonality assessment services.
-
Expertise, Experience, And Commitment Drives Results
2/28/2023
The BioCentriq team of experienced engineers, scientists, researchers, analysts, and operators have expertise in a variety of modalities, equipment, technologies, platforms, and processes.
-
Conquer Complexities With Advanced Mass Spectrometry
Advanced analytical technologies offer critical insights into the structural characterization and quantitation of biotherapeutics, helping to move projects toward clinic and manufacturing on schedule.
-
cGMP Manufacturing - Microbial System
1/25/2024
Learn how our 4,000-square-foot cGMP manufacturing site is purpose-built to support your microbial program from pre-clinical to commercial manufacturing.